Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page
- ChecktodayChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the page, indicating a minor software version update. This change is an internal platform update and does not modify the study data or its history.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe history shows the recruitment status changed to 'No longer looking for participants,' indicating enrollment has ended or is paused. A new version tag 'Revision: v3.6.0' appears, while the previous 'Revision: v3.5.5' is removed.SummaryDifference0.4%

- Check22 days agoChange DetectedThe page history shows a new release identifier (v3.5.5) replacing the previous v3.5.4. This indicates a site-level update to the interface.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision label v3.5.4 appears, replacing the previous v3.5.3 in the record history. This indicates a published update to the page metadata without changing the underlying study details.SummaryDifference0.1%

- Check66 days agoChange DetectedUpdates the ClinicalTrials.gov page revision/version indicator from v3.5.2 to v3.5.3, with no change to the underlying study record content.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.